PE consortium makes $4.6b take-private bid for China Biologic
Centurium Capital, CITIC Capital and Hillhouse Capital are part of an investor group targeting a $4.6 billion take-private of China Biologic – just over a year after committing new equity to the US-listed company to protect it from other would-be acquirers.
The three private equity firms, together with Temasek Holdings, Parfield International and Hong Kong-listed medical device manufacturer PW Medtech Group, are offering to buy all outstanding shares in China...
More on Greater China
Latest News
Philippines PE: Power dynamics
A virtually impenetrable middle market under the control of incumbent conglomerates is the least governable of the systemic obstacles facing private equity hopefuls in the Philippines
GGV backs Singapore dental 3D printing company
GGV Capital has joined a group of investors in a venture round of undisclosed size for Structo, a Singapore-based 3D printing company focused on the dental industry.
Ant Financial invests $92m in Chinese e-signature provider
TSign – a China-based electronic signature service provider – has received RMB650 million ($92 million) in Series C funding led by Alibaba Group affiliate Ant Financial. Other investors include Gobi Partners and Eminence Ventures.